PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Cellular Biology, Histology and Pharmacology, Faculty of Health Sciences, University of Valladolid, Soria, Spain.\', \'Neurobiology Research Group, Faculty of Medicine, University of Valladolid, Valladolid, Spain.\', \'Department of Preventive Medicine and Public Health, School of Medicine, University of Navarra, Navarra Institute for Health Research (IdiSNA), Pamplona, Spain.\', \'Department of Health Sciences, Faculty of Health Sciences, University of Burgos, Burgos, Spain.\', \'Nutrition, Exercise and Healthy Lifestyle Research Group (ImFINE) Research Group, Department of Health and Human Performance, Faculty of Physical Activity and Sport Sciences-National Institute of Physical Education (INEF), Polytechnic University of Madrid, Madrid, Spain.\', \'Dual Enrollment Program, Point University, Savannah, GA, United States.\', \'Cancer Research Centre, University of Salamanca, Salamanca, Spain.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.3389/fimmu.2021.698672
?:doi
?:hasPublicationType
?:journal
  • Frontiers in immunology
is ?:pmid of
?:pmid
?:pmid
  • 34220861
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 2.803
?:rankingScore_hIndex
  • 69
is ?:relation_isRelatedTo_publication of
?:title
  • Glycophosphopeptical AM3 Food Supplement: A Potential Adjuvant in the Treatment and Vaccination of SARS-CoV-2.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all